Pacira BioSciences' Profit After Tax rose 103.79% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 123.63%. This contributed to the annual value of -$99.6 million for FY2024, which is 337.30% down from last year.
Per Pacira BioSciences' latest filing, its Profit After Tax stood at $5.4 million for Q3 2025, which was up 212.07% from -$4.8 million recorded in Q2 2025.
Pacira BioSciences' 5-year Profit After Tax high stood at $25.8 million for Q2 2023, and its period low was -$143.5 million during Q3 2024.
In the last 3 years, Pacira BioSciences' Profit After Tax had a median value of $9.0 million in 2024 and averaged -$4.7 million.
In the last 5 years, Pacira BioSciences' Profit After Tax spiked by 1,666.81% in 2023 and then tumbled by 1,421.29% in 2024.
Pacira BioSciences' Profit After Tax (Quarterly) stood at -$5.1 million in 2021, then crashed by 96.92% to -$10.1 million in 2022, then soared by 346.19% to $24.9 million in 2023, then plummeted by 35.50% to $16.0 million in 2024, then spiked by 103.79% to $5.4 million in 2025.
Its last three reported values are $5.4 million in Q3 2025, -$4.8 million for Q2 2025, and $4.8 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value